Printer Friendly

VIAGENE OVER-ALLOTMENT OPTION EXERCISED

 SAN DIEGO, Jan. 17 /PRNewswire/ -- Viagene, Inc. (NASDAQ: VIGN) today announced that its underwriters have exercised the option to offer an over-allotment of 300,000 shares. This announcement follows the recent completion of its initial public offering (IPO) last month of 2,000,000 shares of common stock at $9.00.
 The Viagene offering was managed by Alex. Brown & Sons, CS First Boston and Nomura Securities International, Inc. Trading of Viagene's common shares commenced December 16, on the NASDAQ Stock Market. Copies of the final prospectus relating to the public offering may be obtained from Alex. Brown & Sons, Inc., 410-727-1700, CS First Boston, Municipal Securities Division, 212-909-3210, and Nomura Securities International, Inc., 212-667-2460.
 Viagene, Inc. is a biotechnology company located in San Diego, that is pursuing the discovery, development and commercialization of gene transfer drugs for the treatment of severe viral infections, cancers and other diseases.
 -0- 1/17/94
 /CONTACT: Jeff Works, chief financial officer, president and CEO of Viagene, Inc., 619-452-1288, or Anthony J. Russo, Ph.D. of Noonan/Russo Communications, 212-696-4455, ext. 202/
 (VIGN)


CO: Viagene, Inc. ST: California IN: MTC SU:

WB-CK -- NY005 -- 2379 01/17/94 08:30 EST
COPYRIGHT 1994 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 17, 1994
Words:194
Previous Article:FED-UP SHOPPERS TUNE IN ELECTRONIC SHOPPING WHEN THEY TUNE OUT POOR SERVICE IN STORES
Next Article:ON THE BORDER CAFES, INC. MAKES ANNOUNCEMENT
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters